drugset / Trial / NCT03057054
Lactobacillus Plantarum in Preventing Acute Graft Versus Host Disease in Children Undergoing Donor Stem Cell Transplant
Phase 3
Active not recruiting
173 enrolled
Children's Oncology Group
National Cancer Institute (NCI) · collab
RandomizedParallel-groupDouble-blindPrevention
Summary
This randomized phase III trial studies how well Lactobacillus plantarum works in preventing acute graft versus host disease in children undergoing donor stem cell transplant. Lactobacillus plantarum may help prevent the development of gastrointestinal graft versus host disease in children, adolescents, and young adults undergoing donor stem cell transplant.
Timeline
- Start
- 2018-04-30
- Primary completion
- 2022-06-30
- Completion
- 2026-06-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Lactobacillus plantarum 299v | Other / unclassified | — | Oral |
| Subject | Lactobacillus plantarum strain 299 | Unknown | — | Oral |